BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.290
+0.050 (4.03%)
At close: Feb 27, 2026, 4:00 PM EST
1.320
+0.030 (2.33%)
After-hours: Feb 27, 2026, 7:59 PM EST
BioCardia Market Cap
BioCardia has a market cap or net worth of $13.69 million as of February 27, 2026. Its market cap has increased by 18.98% in one year.
Market Cap
13.69M
Enterprise Value
9.04M
1-Year Change
18.98%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $13.69M, a decrease of -52.91%. That is a compound annual growth rate of -7.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 13.16M | -0.80% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 14.75M |
| Quantum BioPharma | 13.76M |
| NewcelX | 13.08M |
| Traws Pharma | 12.95M |
| Edesa Biotech | 12.94M |
| BioLineRx | 12.52M |
| GT Biopharma | 12.50M |
| Iterum Therapeutics | 12.47M |